Characterization of rat CD80 and CD86 by molecular cloning and mAb

被引:42
作者
Maeda, K
Sato, T
Azuma, M
Yagita, H
Okumura, K
机构
[1] JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,BUNKYO KU,TOKYO 113,JAPAN
[2] NATL CHILDRENS MED RES CTR,DEPT ALLERGY & IMMUNOL,SETAGAYA KU,TOKYO 154,JAPAN
[3] JAPAN SCI & TECHNOL CORP,CREST,CHIYODA KU,TOKYO 101,JAPAN
关键词
CD80; CD86; co-stimulatory signal; rat;
D O I
10.1093/intimm/9.7.993
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CD28/B7 pathway provides a critical co-stimulatory signal for T cell activation. In the present study, we cloned rat CD80 and CD86 cDNA from a HTLV-1-transformed rat T cell line, Lewis-S1, expressing a high level of CTLA-4-lg binding proteins, The predicted CD80 and CD86 polypeptides were composed of 321 and 313 amino acids respectively, and exhibited features common to human and mouse B7 family proteins, Both CD80 and CD86 mRNAs were abundantly detected in HTLV-1-transformed rat T cell lines but not in a thymic lymphoma cell line. To further explore the function of rat CD80 and CD86, we generated cDNA transfectants and anti-rat CD80 (3H5) and anti-rat CD86 (24F) mAb, Rat CD80 or CD86 transfectants exhibited a potent co-stimulatory activity for rat T cell proliferation, which was blocked by 3H5 and 24F mAb respectively, 3H5 or 24F immunoprecipitated a 80-90 or 90-100 kDa surface protein from Lewis-S1 cells, HTLV-1-transformed rat T cell lines expressed high levels of both CD80 and CD86 as estimated by staining with 3H5 and 24F, which acted co-stimulatory for allogeneic T cell activation as estimated by blocking with 3H5 and 24F. These mAb will be useful for investigating the pathophysiological functions of CD80 and CD86 in transplantation, autoimmune diseases and HTLV-1-associated pathologies in the rat system.
引用
收藏
页码:993 / 1000
页数:8
相关论文
共 48 条
  • [1] Arima T, 1996, J IMMUNOL, V156, P4916
  • [2] MOLECULAR-CLONING OF A CD28 CDNA BY A HIGH-EFFICIENCY COS CELL EXPRESSION SYSTEM
    ARUFFO, A
    SEED, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) : 8573 - 8577
  • [3] B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28
    AZUMA, M
    ITO, D
    YAGITA, H
    OKUMURA, K
    PHILLIPS, JH
    LANIER, LL
    SOMOZA, C
    [J]. NATURE, 1993, 366 (6450) : 76 - 79
  • [4] Barney-Knoerzer D., 1995, J CLIN INVEST, V96, P987
  • [5] Bashuda H, 1996, TRANSPLANT P, V28, P1039
  • [6] CHEN CY, 1994, J IMMUNOL, V152, P4929
  • [7] TREATMENT OF MURINE LUPUS WITH CTLA4IG
    FINCK, BK
    LINSLEY, PS
    WOFSY, D
    [J]. SCIENCE, 1994, 265 (5176) : 1225 - 1227
  • [8] FREEMAN GJ, 1989, J IMMUNOL, V143, P2714
  • [9] CLONING OF B7-2 - A CTLA-4 COUNTER-RECEPTOR THAT COSTIMULATES HUMAN T-CELL PROLIFERATION
    FREEMAN, GJ
    GRIBBEN, JG
    BOUSSIOTIS, VA
    NG, JW
    RESTIVO, VA
    LOMBARD, LA
    GRAY, GS
    NADLER, LM
    [J]. SCIENCE, 1993, 262 (5135) : 909 - 911
  • [10] STRUCTURE, EXPRESSION, AND T-CELL COSTIMULATORY ACTIVITY OF THE MURINE HOMOLOG OF THE HUMAN LYMPHOCYTE-B ACTIVATION ANTIGEN-B7
    FREEMAN, GJ
    GRAY, GS
    GIMMI, CD
    LOMBARD, DB
    ZHOU, LJ
    WHITE, M
    FINGEROTH, JD
    GRIBBEN, JG
    NADLER, LM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (03) : 625 - 631